Hyalex Orthopaedics was granted FDA 510(k) clearance to market the HYALEX Slalom MTP Hemiarthroplasty Implant, a next-generation implant designed around the proprietary Hydrosurf materials platform, for the treatment of degenerative conditions affecting the first metatarsophalangeal (MTP) joint, including hallux rigidus.
Hydrosurf material is a proprietary surface technology designed to closely replicate the biomechanical properties of native cartilage. Together with its advanced implant geometry, the system is designed to reduce pain, maintain range of motion, and provide a reliable alternative to traditional fusion procedures.
The clearance enables the company’s first commercial product launch in the United States and marks its entry into the growing foot and ankle reconstruction market. Limited U.S. release will commence, followed by a full commercial rollout later this year.
Hyalex Orthopaedics was granted FDA 510(k) clearance to market the HYALEX Slalom MTP Hemiarthroplasty Implant, a next-generation implant designed around the proprietary Hydrosurf materials platform, for the treatment of degenerative conditions affecting the first metatarsophalangeal (MTP) joint, including hallux rigidus.
Hydrosurf material is...
Hyalex Orthopaedics was granted FDA 510(k) clearance to market the HYALEX Slalom MTP Hemiarthroplasty Implant, a next-generation implant designed around the proprietary Hydrosurf materials platform, for the treatment of degenerative conditions affecting the first metatarsophalangeal (MTP) joint, including hallux rigidus.
Hydrosurf material is a proprietary surface technology designed to closely replicate the biomechanical properties of native cartilage. Together with its advanced implant geometry, the system is designed to reduce pain, maintain range of motion, and provide a reliable alternative to traditional fusion procedures.
The clearance enables the company’s first commercial product launch in the United States and marks its entry into the growing foot and ankle reconstruction market. Limited U.S. release will commence, followed by a full commercial rollout later this year.
Copy to clipboard 
